To investigate the effect of ginsenoside Rb1 on voltage-gated calcium currents in cultured rat hippocampal neurons and the modulatory mechanism. Methods: Cultured hippocampal neurons were prepared from Sprague Dawley rat embryos. Whole-cell configuration of the patchclamp technique was used to record the voltage-gated calcium currents (VGCCs) from the hippocampal neurons, and the effect of Rb1 was examined. Results: Rb1 (2-100 μmol/L) inhibited VGCCs in a concentration-dependent manner, and the current was mostly recovered upon wash-out. The specific L-type Ca 2+ channel inhibitor nifedipine (10 μmol/L) occluded Rb1-induced inhibition on VGCCs. Neither the selective N-type Ca 2+ channel blocker ω-conotoxin-GVIA (1 μmol/L), nor the selective P/Q-type Ca 2+ channel blocker ω-agatoxin IVA (30 nmol/L) diminished Rb1-sensitive VGCCs. Rb1 induced a leftward shift of the steady-state inactivation curve of I Ca to a negative potential without affecting its activation kinetics or reversal potential in the I-V curve. The inhibitory effect of Rb1 was neither abolished by the adenylyl cyclase activator forskolin (10 μmol/L), nor by the PKA inhibitor H-89 (10 μmol/L). Conclusion: Ginsenoside Rb1 selectively inhibits the activity of L-type voltage-gated calcium channels, without affecting the N-type or P/Q-type Ca 2+ channels in hippocampal neurons. cAMP-PKA signaling pathway is not involved in this effect.
Introduction
Ca 2+ , an important regulator of neuronal activity, controls membrane excitability, triggers the release of neurotransmitters and mediates activity-dependent changes in gene expression. Voltage-gated Ca 2+ channels play a key role in the control of free cytosolic Ca 2+ [1] . According to their pharmacological and electrophysiological properties, at least 5 distinct types of voltage-gated Ca 2+ channels have been identified and designated as L, N, P/Q, R, and T [2, 3] . L-, N-, and P/Q-type Ca 2+ channels are pharmacologically identified and characterized by their specific blockers. Nifedipine is an L-type Ca 2+ channel inhibitor, ω-conotoxin GVIA is an N-type Ca 2+ channel inhibitor, and ω-agatoxin IVA is a P/Q-type Ca 2+ channel inhibitor [4] [5] [6] [7] [8] [9] . Because the elevation of intracellular Ca 2+ levels ([Ca 2+ ] i ) caused by the excessive stimulation of Ca 2+ channels plays a key role in the excitotoxic damage of neurons, agents blocking the elevation of [Ca 2+ ] i by regulating Ca 2+ channels might have neuroprotective effects [10] [11] [12] . Ginseng, the root of Panax ginseng CA Meyer, has been used worldwide as an herbal medicine for the alleviation of many ailments, particularly those associated with aging and memory deterioration. Ginsenoside Rb1, a protopanaxadiol type saponin, is one of the most important active compounds of ginseng. Recently, ginsenoside Rb1 has been reported to effectively protect neurons from glutamate-induced toxicity and β-amyloid (Aβ)-induced toxicity by reducing intracellular Ca 2+ levels [13] [14] [15] [16] [17] [18] 
Materials and methods

Materials
Ginsenoside Rb1 was obtained from the Department of Organic Chemistry at Jilin University (Changchun, China) with a purity >98%. Stock solutions of the Ca 2+ channel antagonists, ω-conotoxin GVIA (Alomone Labs, UK), nifedipine (Sigma, UK) ω-agatoxin IVA (Alomone Labs, UK) and adenylyl cyclase agonist Forskolin (Sigma, UK), were prepared with the appropriate amounts of deionized water or dimethyl sulfoxide (DMSO) and frozen at -20 °C before appropriate dilution in the recording medium. H-89 was dissolved in the pipette solution (described below) and stored at -20 °C. After the whole-cell configuration was obtained, H-89 was dialyzed into the cell through the pipette.
Hippocampal neuron cultures
Chemical media and culture media were obtained from Sigma unless otherwise noted. The care and use of animals followed the guidelines of the Shanghai Institutes for Biological Sciences Animal Research Advisory Committee. The hippocampal neuron cultures were prepared as described previously [19] with some modifications. Briefly, whole brains were isolated from 18-day-old SD rat embryos, and the hippocampi were dissected and treated with 0.125% trypsin at 37 °C for 12 min. The cells were suspended with Dulbecco's Modified Eagle's Medium (DMEM) (GIBCO) containing 10% fetal bovine serum (HyClone, Logan, UT, USA) and 10% F-12 (GIBCO) and were plated at a density of 60 000 cells/mL on poly D-lysine-coated 35 mm dishes (Costar). Twenty-four hours after plating, half of the medium was changed to serum-free Neurobasal (NB) medium with 2% B27 supplement (GIBCO) and 1% glutamine. Thereafter, half of the changed medium was replaced twice a week with NB medium containing 2% B27 supplement and 0.25% glutamine. After 7 d in vitro, glial cell proliferation was inhibited by exposure to 2-4 mmol/L cytosine arabinoside. All the recordings were made with cells between d 6 and 8.
Electrophysiological recordings
Single patch recordings of Ca 2+ channels from cultured hippocampal neurons at 6-8 d in vitro were made at room temperature using an EPC-9 patch-clamp amplifier and its corresponding Patchmaster software (Heka Electroniks, Germany) or an Axopatch-200B amplifier (Axon Instruments) with pCLAMP acquisition software. The gain was set to 1, filtered at 1 kHz, stored on videotape after digitization with a PCM processor, and displayed with a thermal pen recorder. The membrane capacitance and series resistance compensation were optimized.
Patch pipettes were fabricated from borosilicate glass capillaries (outer diameter 1.2 mm, inner diameter 0.69 mm, length 7.5 cm; B-120-69-15, Sutter Instruments) on a horizontal puller (Sutter Instruments). The microelectrodes had tip diameters of 2-3 µm and resistances of 3-6 MΩ. The pipettes were filled with an intracellular solution containing 80 mmol/L Csmethanesulfonate, 20 mmol/L tetraethylammonium chloride (TEA-Cl), 1 mmol/L CaCl 2 , 5 mmol/L MgCl 2 , 11 mmol/L ethylene glycole-bis-(2-aminoethyl)-tetraacetic acid (EGTA), 10 mmol/L N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES), and 10 mmol/L Na 2 ATP. The chemicals were obtained from Sigma. CsOH was used to adjust the pH to 7.2-7.3. The osmolarity of the pipette solution was adjusted to 300 mOsm with sucrose. As suggested by Smirnov [20] , the replacement of 1.5 mmol/L Ca 2+ with 5 mmol/L Ba 2+ was used to augment the amplitude of the inward current through Ca 2+ channels. The potential dependency of activation and inactivation with 5 mmol/L Ba 2+ was very similar to the results observed in 1.5 mmol/L Ca 2+ . To isolate the Ba 2+ current (I Ba ), the following reagents were used for the external solution: 115 mmol/L choline-Cl, 25 mmol/L TEA-Cl, 5 mmol/L 4-aminopyridine (4-AP), 5 mmol/L BaCl 2 , 10 mmol/L glucose, 10 mmol/L HEPES, and 0.0005 mmol/L tetrodotoxin (TTX). Tris was used to adjust the pH to 7.4. The osmolarity of the extracellular solution was adjusted to 300 mOsm with sucrose. 4-AP and TEA were used to eliminate outward K + currents. TTX was used to eliminate inward Na + currents. We recorded the voltage-gated calcium channel Ba 2+ current (I Ba ) and used the following stimulating programs: an activation procedure and a drug application program. For the activation procedure, the cells were held at a potential of -60 mV and depolarized to potentials ranging from -70 mV to +70 mV with 10 mV as a step for a duration of 150 ms, and the steps were repeated every 10 s. For the drug application program, the cells were held at a potential of -60 mV and depolarized to 0 mV (0-+20 mV) for a duration of 200 ms, and the steps were repeated every 10 s.
Experimental drug application and treatment
The "U-tube" solution exchange method [21, 22] was used to apply the drugs. The whole cell measurements were initiated 5 min after break-in. Little run-down was observed during the 15 min necessary to collect the data. The current amplitudes of the cell before and after the experiment and the current densities of the cells of the different groups were compared.
Analysis of the electrophysiological recordings
The current recordings were analyzed using Clampfit 8.0 software (Axon, USA). Further analyses were performed using Microsoft Excel 2003 and Microcal Origin 8.0. All the data were described as the mean±the standard error of the mean. All the current recordings were normalized according to the whole cell capacitance to give the current density. A repeated measures ANOVA with Tukey-Kramer's post-test was used to compare the differences among entire current-voltage (I-V) relationships, and an unpaired Student's t-test was used to compare points on different curves that were activated by stepping to the same potential. P values less than 0.05 were www.nature.com/aps Lin ZY et al Acta Pharmacologica Sinica npg considered significant. The peak current was measured as the maximal current observed during the depolarizing step.
The calcium current steady-state activation curve was fitted to a Boltzmann equation of the following form:
where I is the voltage-dependent current amplitude, V is the membrane potential for activation, V 1/2 is the voltage at which activation is half maximal, and k is the slope factor.
Results
Voltage-gated calcium channel currents in hippocampal neurons
We recorded the whole-cell membrane currents from the somatic region of the neurons ( Figure 1A ) and identified a potent Ca 2+ channel antagonist by its sensitivity to cadmium. We successively discriminated N-, P/Q-, and L-type Ca 2+ channels by their specific blockers. ω-conotoxin GVIA and ω-agatoxin IVA showed irreversible blocking effects, while nifedipine exerted a partially reversible blocking effect ( Figure  1B) .
Effect of ginsenoside Rb1 on VGCCs in hippocampal neurons
The method of extracellular micro-perfusion was used to study the effects of Rb1 on VGCCs. In these experiments with Rb1 treatment, only the peak currents were selected for comparison, and the current was evoked by a pulse of 200 ms duration from -60 mV to 0 mV (0-+20 mV). The inhibition rate of the I Ba peak current was calculated as follows: [(maximum current value before administration -maximum current value after administration)/maximum current value before administration×100%]. The control group was treated with the extracellular solution, and the experimental groups were treated with 1, 2, 5, 10, and 100 μmol/L Rb1. Both the control group and the 1 μmol/L Rb1 group showed no inhibitory effects on the I Ba (Figure 2A, 2B) . However, the other experimental groups with 2, 5, 10, and 100 μmol/L Rb1 demonstrated inhibitory effects on the I Ba. The inhibition rates were 2%±0.87% (n=6), 5%±1.78% (n=4), 20%±3.96% (n=9), and 40%±6.71% (n=5), respectively. The I Ba peak current inhibition rate of each group was significantly higher than that of the previous dose group (P<0.01) ( Table 1 ). The effects of Rb1 on the I Ba were partially reversible after wash-out with the bathing solution ( Figure 2C,  2D) .
Mechanism of action of ginsenoside Rb1 on the VGCCs in hippocampal neurons
The I Ba was still elicited by depolarizing from -60 mV to 0 mV (0-+20 mV) and recorded continuously every 10 s. Under the maximum activated voltage, the currents achieved stability after recording 5 to 6 times. As shown in Figure 3A , 10 μmol/L ginsenoside Rb1 inhibited the I Ba by 21.53%±2.81% (n=5). The inhibitory effect was eliminated after the application of nifedipine, a selective blocker of L-type Ca 2+ channels. As shown in Figure 3B , 10 μmol/L Rb1 inhibited the I Ba by 20.19%±2.98% (n=5) before ω-conotoxin-GVIA treatment and inhibited the I Ba by 20.51%±3.15% (n=5) in the presence of ω-conotoxin-GVIA (P>0.05 compared to Rb1 treatment alone). As shown in Figure 3C To gain a better understanding of the action of Rb1 on the I Ba , we explored its action on the I-V curve and the steady-state inactivation curve of the I Ba . A dose of 10 μmol/L ginsenoside Rb1 inhibited the I Ba at the maximum amplitude (control: I Ba =752.56±48.42 pA, Rb1: I Ba =600±40.70 pA, P<0.01, n=6), but had no effect on the activation threshold potential or the reversal potential of the I Ba in the I-V relationship (Figure 4) . Ginsenosides, which are the pharmacologically active ingredients of Panax ginseng, produce reversible and selective inhibitory effects on voltage-dependent and ligand-gated ion channels [23] [24] [25] [26] . Studies have also found that the mechanisms of action of saponins vary due to their types or the cell types they act on. For example, ginsenosides activate Gα q/11 , a protein coupled to PLC, leading to IP 3 -dependent endoplasmic reticulum calcium release in Xenopus oocytes. However, this effect does not occur in neurons [27] . Although previous studies have reported the diversity of voltage-dependent Ca 2+ channels in hippocampal neurons, and this diversity was also confirmed in the present experiment, none of the research literature mentions the action of the ginsenoside Rb1 on VGCCs in hippocampal neurons. We found that Rb1 at a concentration range of 1 to 100 μmol/L inhibited the calcium channel currents of hippocampal neurons in a dose-dependent manner.
The I Ca peak current inhibition rate paralleled the increase of Rb1 concentration, and the inhibitory effect was mostly reversible.
Most studies support the effect of Rb1 in preventing neuronal death linked to neurodegenerative diseases [13, 15, 28, 29] . Its perturbed neuronal Ca 2+ homeostasis is implicated in aging and age-related cognitive impairments [12] . Chen also showed that it could decrease the Aβ-induced elevation of intracellular calcium and stabilize microtubule integrity [18] . It is widely known that postsynaptic [Ca 2+ ] i and L-type voltage-gated calcium channel currents are upregulated in the hippocampus during aging, despite a significant decrease of cell density [30] . Elevated postsynaptic [Ca 2+ ] i and L-type voltage-gated calcium channel activity contribute to impaired synaptic plasticity [31] and working memory [32] in aged hippocampal neurons. The increase of L-type voltage-gated calcium channel currents also enhances the susceptibility of aging neurons for apoptosis. Fu has shown that the cholinesterase inhibitor tacrine can reduce Aβ-induced neuronal apoptosis by regulating L-type voltagegated calcium channel activity [33] . Our results show that the ginsenoside Rb1 selectively targets L-type calcium channels by inhibiting voltage-gated calcium channels. Different calcium channels have distinct electrophysiological characteristics and are closely related to different cell functions. For example, ginsenoside selectively acts on the non-L-type calcium channels of chromaffin cells, which are related to the regulation of the secretion of catecholamines [34] . Additionally, ginsenoside Rf selectively acts on the N-type calcium channels of sensory neurons, which are related to the inhibition of neurotransmitter release following painful stimuli [35] . Therefore, we infer that the selective action of Rb1 on the L-type calcium channels of hippocampal neurons may be the cellular basis of its pharmacological effects in preventing neuronal death linked to neurodegenerative diseases.
In this study, Rb1 induced a leftward shift of the steady- Protein phosphorylation modulates the function of VGCCs, and the AC-cAMP-PKA system plays a key role in this phosphorylation [36, 37] . Therefore, we used forskolin and H-89 to investigate whether the action of Rb1 on the I Ca is involved in this mechanism. We found that co-application of forskolin and Rb1 did not affect the reduction caused by Rb1. Additionally, the action of Rb1 was not affected by H-89, indicating that the cAMP-PKA system might not be involved in the mechanism by which Rb1 reduces the I Ca . These results confirmed our previous speculation that it is difficult to achieve Ca 2+ channels phosphorylation within 10 s.
In summary, this study provides electrophysiological evidence that Rb1 induces calcium current inhibition by inhibiting the activity of the L-type Ca 2+ channels in hippocampal neurons. This finding raises the possibilities that Rb1 may be useful and potentially therapentic choices in the treatment of neurological disorders.
